Honeywell Q2 Beats, Guidance Raised; DeepValue Report Flags Cash Quality Risks

What happened

Honeywell reported strong Q2 results and raised forward guidance, driven by sustained aerospace aftermarket demand and progress on its portfolio transformation following the Solstice spin-off. The company's simplified structure is viewed as a catalyst for its Automation business, with management reiterating a Q3 2026 timeline for the Aerospace separation. However, the DeepValue master report cautions that the 29.1x P/E and 19.6x EV/EBITDA already price in a clean separation, leaving no margin of safety. The report highlights that reported free cash flow guidance of $5.3–5.6B includes ~$1.9B of adjustments (spin costs, Flexjet settlement), meaning distributable cash is significantly lower. Additionally, 4Q25 saw Aerospace margin compression of 60 bps ex-Bombardier, indicating volume strength alone does not protect profitability.

Implication

The Q2 beat and raised guidance validate strong end-market demand, but the elevated multiple leaves no room for execution missteps. Investors should focus on the June 2026 Aerospace Investor Day for standalone financial targets and Form 10 progress. The key risk is that headline FCF masks adjusted cash flows, while margin compression in Aerospace suggests cost pressures persist. Until a credible normalized cash framework is provided and separation timeline is locked, the risk/reward is unattractive. A pullback toward $220 would offer a better entry point with improved margin of safety.

Thesis delta

The article's positive outlook post-spin-off is consistent with the base case of a Q3 2026 separation and robust aerospace demand, but the DeepValue report's emphasis on cash quality adjustments and margin pressure suggests the upside is already priced in. The thesis shifts slightly toward caution: the market is too optimistic about cash generation and margin expansion, and realization of value depends on clarity from the upcoming Investor Day and Form 10 effectiveness. There is no material change to the overall WAIT rating, but the risk of timeline slippage or cost inflation remains underappreciated.